What is AbbVie's deferred taxes?

AbbVie (ABBV) reported deferred taxes of $137M in Q1 2026.

How has AbbVie's deferred taxes changed year-over-year?

AbbVie's deferred taxes increased by 589.3% year-over-year, from -$28M to $137M.

What is the long-term trend for AbbVie's deferred taxes?

Over 3 years (2021 to 2024), AbbVie's deferred taxes has grown at a 17.3% compound annual growth rate (CAGR), from -$898M to -$1.45B.

What does deferred taxes mean?

Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.

AbbVie ABBV Deferred Taxes

Deferred Taxes at other companies

Eli LillyLLY

$1.48B+277%

PfizerPFE

-$12M+98.2%

Johnson & JohnsonJNJ

$159M-92.7%

AmgenAMGN

-$176M+29.6%

Cardinal HealthCAH

$60.75M+334%

IncyteINCY

$63.42M+1,046%

Other financials

Income statement

See full

Revenue$15.0B+12.4%

Gross profit$10.8B+15.4%

Operating income$4.0B+6.9%

Net income$695.0M-46.0%

EPS (diluted)$0.39-45.8%

Balance sheet

See full

Cash & equivalents$9.4B+81.5%

Total debt$62.4B+1.8%

Total equity-$6.7B-569%

Total assets$136.46B+0.2%

Cash flow

See full

Operating cash flow$3.8B+134%

CapEx$265.0M+12.8%

Free cash flow$3.6B+155%

Valuation

See full

Market cap$444.6B+39.8%

P/E122.3×+37.8×

P/S7.1×+1.6×

Profitability

See full

Gross margin70.7%0.0pp

Operating margin24.4%—

Net margin5.8%-1.5pp

FCF margin31.8%+5.0pp

Returns & leverage

See full

Return on equity89%+32.7pp

Debt / equity46.6×+38.6×

Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbbVie's deferred taxes?: AbbVie (ABBV) reported deferred taxes of $137M in Q1 2026.
How has AbbVie's deferred taxes changed year-over-year?: AbbVie's deferred taxes increased by 589.3% year-over-year, from -$28M to $137M.
What is the long-term trend for AbbVie's deferred taxes?: Over 3 years (2021 to 2024), AbbVie's deferred taxes has grown at a 17.3% compound annual growth rate (CAGR), from -$898M to -$1.45B.
What does deferred taxes mean?: Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.